The PLI scheme provides financial incentives for manufacturers to establish or expand their manufacturing activities in India; therefore encouraging both Indian and global manufacturers to set up manufacturing within India, according to Prashant Krishnan, CEO of TI Medical.
He believes that this initiative will assist in building India’s medical technology manufacturing base and provide opportunities for India to become a global centre for advanced manufacturing of medical devices.
Featured in the cover story, “India’s Rise as a Global MedTech Hub,” he explores the role of innovation, manufacturing capabilities, and policy support in driving the next phase of growth for the industry.
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
Read more
India’s healthcare system faces growing pressure from chronic disease, air pollution, and workforce shortages. Ahead of Union Budget 2026, medical professionals and healthcare stakeholders have outlined what they believe the health budget must fix.
Read more
As the Union Budget 2026–27 approaches, scheduled for February 1, industry leaders are urging the government to focus on policies that drive long-term growth, investment, and inclusion, rather than short-term headlines. Across sectors—from fintech and FMCG to real estate and healthcare—the message is clear: stability, clarity, and targeted support are the need of the hour.
Read moreStrong government policy, entrepreneurial drive and increased clinical development makes advanced medical devices readily available to the people of India. The medtech market in India is undergoing a momentous transition over the course of this next decade, says Prashant Krishnan, CEO, TI Medical.
Read more
TI Medical, has launched Ubersonic Synergy at the 10th edition of GEM LAPAROSURG 2025 in Coimbatore, followed by the unveiling of its Premium Suture range in Mumbai. Together, these launches mark another strong step forward in TI Medical’s mission to elevate surgical precision, safety, and performance across specialities.
TI Medical, one of India’s fastest-growing names in advanced surgical device innovation, has officially unveiled its next-generation hernia repair mesh — HIPO. India’s leading laparoscopic and gastrointestinal surgeons participated in the launch, marking a major leap forward in the company’s vision to deliver precision-engineered surgical solutions designed to improve patient outcomes and procedural efficiency.
Read more
TI Medical, one of India’s fastest-growing innovators in surgical device solutions, has unveiled its next-generation hernia repair mesh , HIPOM, a cutting-edge innovation designed to enhance surgical precision and patient comfort. The product was launched at an exclusive event at JW Marriott, Kolkata, in the presence of leading laparoscopic GI surgeons from the region.
Read more
TI Medical, one of India’s innovators in the medical technology sector, unveiled its Premium Suture product range at MedTech Expo 2025, held from September 4 to 6 at Bharat Mandapam, New Delhi. The launch was led by Aseem Sahu, Deputy Drugs Controller, Medical Device Division, alongside Prashant Krishnan, CEO of TI Medical, and the company’s leadership team.
Read more
India’s MedTech market is slated to reach an estimated USD 17 billion by 2025, growing rapidly due to rising chronic disease awareness, improved diagnostic capabilities, expanding insurance coverage, and access to advanced treatments across Tier 1, 2, and 3 cities. Despite India currently importing over 75 per cent of its medical devices, government policies like the National Medical Device Policy and initiatives promoting Make in India are driving a shift toward robust domestic manufacturing.
Read more
Govind Malpani has been appointed as Chief Financial Officer & Head of Finance, IT and Supply Chain Management at TI Medical, a Murugappa Group company. This appointment is part of a senior leadership expansion to drive innovation and global growth. Malpani's expertise will be crucial in scaling the company's vision of 'Make in India, Make for the World'.
Read more
TI Medical, part of the Murugappa Group, has appointed three senior executives to its management team as part of its ongoing business expansion in the MedTech sector.
Read more
TI Medical, a Murugappa Group company, has appointed three senior executives to its leadership team as part of its efforts to expand globally and strengthen operations under its ‘Make in India, Make for the World’ mission.
Read more
TI Medical, part of the Murugappa Group, has strengthened its leadership structure with the induction of three senior executives, signalling its intent to accelerate innovation, global market outreach, and operational scale.
Read more
Govind Malpani has recently been appointed as the Chief Financial Officer and Head – Finance, IT & Supply Chain Management at TI Medical, marking a significant milestone in his accomplished career in finance and operations. With nearly two decades of experience across leading organisations in the healthcare and FMCG sectors, Govind steps into this leadership role with a robust track record of financial strategy, operational excellence, and cross-functional management.
Read more
New Delhi, 16 July 2025: TI Medical, a Murugappa Group company, was recently honoured on the same day with two prestigious awards by two of India’s leading financial publications, in recognition of its leadership in the country’s healthcare and medical technology space.
New Delhi, 16 July 2025: TI Medical, a Murugappa Group company, was recently honoured on the same day with two prestigious awards by two of India’s leading financial publications, in recognition of its leadership in the country’s healthcare and medical technology space.
Read more
New Delhi, 16 July 2025: TI Medical, a Murugappa Group company, was recently honoured on the same day with two prestigious awards by two of India’s leading financial publications, in recognition of its leadership in the country’s healthcare and medical technology space.
Read more
TI Medical, a Murugappa Group company, was recently honoured on the same day with two prestigious awards by two of India’s leading financial publications, in recognition of its leadership in the country’s healthcare and medical technology space.
Read more
How does TI Medical differentiate itself from other Medtech product companies?
Read more
New Delhi: TI Medical has announced the appointment of Prashant Krishnan as its Chief Executive Officer (CEO). With over 28 years of experience in the medical device industry, Prashant is set to lead the next phase of growth and innovation at TI Medical.
Read moreTI Medical has announced the appointment of Prashant Krishnan as its Chief Executive Officer (CEO). With over 28 years of experience in the medical device industry, Prashant is set to lead the next phase of growth and innovation at TI Medical. His leadership is expected to advance the company’s growth trajectory and strengthen its position as a global leader in the healthcare and medtech industry.
Read moreTube Investments of India Limited (TII) and Premji Invest have acquired 100 percent equity of Lotus Surgicals Private Limited. TII will acquire 67 percent while Premji Invest will acquire the remaining 33 percent, subject to the completion of certain conditions precedent. The acquisition is the first step for TII and Premji Invest to initiate a Medtech Platform partnership.
Read moreMurugappa Group's engineering firm Tube Investments of India and Azim Premji's private equity fund, Premji Invest, announced on Saturday that together they would be acquiring Lotus Surgicals Pvt., a maker of wound closure products, for a sum of Rs 348 crore.
Read moreThe Murugappa Group company has been reshaping its business over the past two years through venture capital fund-type investments and turning around distressed companies.
Analysts are still waiting for a clearer picture to emerge on how the pharma foray and medical-devices buy will play out for Tube Investments.
Read moreMurugappa group company Tube Investments of India (TII) and Premji Invest (through PI Opportunities Fund I Scheme II) have signed a share purchase agreement to acquire 100% equity capital of Lotus Surgicals from India Medical Consumables Holdings Limited (a Samara Capital entity) and other shareholders.
Read moreThe acquisition is the first step for Tube Investments of India and Premji Invest to initiate a medtech platform partnership.
Tube Investments of India ('TII') and Premji Invest (through PI Opportunities Fund I Scheme II) on Friday, 24 March 2023, signed a share purchase agreement to acquire 100% equity capital of Lotus Surgicals ('Lotus') from India Medical Consumables Holdings (a Samara Capital entity) and other shareholders.
Read moreMurugappa Group’s engineering firm Tube Investments of India (TII) and Azim Premji Foundation’s Premji Invest have joined hands to acquire Lotus Surgicals Pvt Ltd, which is engaged in the business of wound closure products, for an estimated sum of ?348 crore.
Read more
Tube Investments of India (TII), part of Rs 54,722-crore Murugappa Group and Premji Invest (through PI Opportunities Fund) on Saturday signed a share purchase agreement to acquire 100% equity capital of Lotus Surgicals from India Medical Consumables Holdings (a Samara Capital entity) and other shareholders.
Read more